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Abstract 
Background: The incidence of diabetes mellitus is increasing worldwide, resulting in a global epidemic. The most 
common type, the type 2 diabetes mellitus, constitutes of 90–95 % of the cases and is characterized by the action of 
and/or impaired insulin secretion. Regular exercise is a recommended strategy in several studies and guidelines for 
type 2 diabetes control and complications associated with it. Therefore, we evaluated and compared the effects of 
aerobic and strength exercise programs on the glycemic control in patients with type 2 diabetes.
Methods: The selected patients were divided into groups which performed moderate strength training (ST) and 
aerobic training (AT). The study lasted 20 weeks and was divided into two 10 week phases with anthropometric (body 
mass index, waist, abdomen and hips circumferences, waist/hip ratio) and biochemical (glycemic and lipid profile) 
assessments at baseline, 10 weeks and 20 weeks. For intra and inter analyses a mixed ANOVA model was used. Indi‑
vidual changes were calculated using the minimum detectable change, based on a 90 % confidence interval.
Results: Eleven patients (five men and six women) completed the 20 weeks of training; five from the ST group 
and six from the AT. No significant changes were observed in any anthropometric variable in either group. Statisti‑
cally significant differences were found in mean hemoglobin A1c in both groups between baseline (AT: 8.6 ± 2.5; ST: 
9.2 ± 1.9) and 10 weeks (AT: 7.2 ± 1.7; ST: 7.9 ± 1.2) (p = 0.03), and baseline (AT: 8.6 ± 2.5; ST: 9.2 ± 1.9) and 20 weeks 
(AT: 7.5 ± 1.7; ST: 7.4 ± 0.9) (p = 0.01). For the minimal detectable changes, 40 % of the ST and 33 % of AT achieved 
these changes for hemoglobin A1c.
Conclusion: Both aerobic and strength exercises can help the metabolic control in patients with type 2 diabetes, 
even without significant changes in anthropometry over the 20 weeks of training. However, this period was sufficient 
to cause changes in hemoglobin A1c values and the estimated average glucose, which are important parameters in 
controlling diabetes, thus signaling an important consequence of adhering to an exercise routine for type 2 diabetic 
patients.
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Background
The incidence of diabetes mellitus (DM) is increasing 
worldwide, resulting in a global epidemic [1]. More than 
382 million people are currently affected worldwide, with 
an increase to 592 million forecasted for the year 2035 [2, 
3]. Yet, according to the International Diabetes Federa-
tion, Brazil is the fourth country in the world in number 
of people with DM, with almost 12 million patients [4].
The most common type, the type 2 diabetes mellitus 
(DM 2), makes up 90–95  % of the cases and is charac-
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disease is more common in people older than 45  years 
of age and overweight [2]. However, as a result of the 
increase of obesity among young people, DM 2 is becom-
ing more frequent among children and young adults [5]. 
The increasing prevalence of DM 2 can also be attributed 
to other factors, such as population growth and ageing, 
greater urbanization, the increasing prevalence of obe-
sity and physical inactivity, as well as increased survival 
amongst patients with DM [4, 6].
Regular exercise is a strategy recommended by a 
diverse number of studies, and a guideline to control DM 
2 and its associated complications [3, 7–9] and, in asso-
ciation with food planning and drug therapy, it has been 
regarded as one of the three main components in the 
control and treatment of DM [10]. It is noteworthy that 
diabetes patients demonstrate less aerobic condition-
ing, and lower levels of muscular strength and flexibility 
when compared with unaffected individuals of the same 
age and gender. Diabetics that are physically active and/
or present good aerobic conditioning feature better prog-
nosis than those who are inactive and/or those with low 
aerobic conditioning [6].
Both aerobic and strength exercises can increase insu-
lin action, improve the lipid profile, glycemic levels, blood 
pressure (BP), decrease the risk of cardiovascular dis-
eases, lower body weight [11–13], reduction of mortality 
[14], prevent complications related to DM and improve 
the life quality of diabetics when performed continuously 
[12]. These factors make the inclusion of physical activity 
a fundamental element of a diabetic’s treatment.
As such, the present study aimed to evaluate and 
compare the effects of supervised aerobic exercise and 
strength programs on glycemic control in patients with 
DM 2 treated at the Hiperdia Center of Viçosa, MG.
Methods
Study design
The study was within and between subjects design which 
lasted 20 weeks and was developed as part of the project 
“Evaluation and Treatment of Diabetic and Hypertensive 
Patients Served by the Center Hiperdia of Viçosa”, a part-
nership of the Federal University of Viçosa with the pro-
gram Hiperdia Minas. The study was conducted entirely 
at the Hiperdia Center in Viçosa/MG. The project was 
approved by the Committee of ethics in research with 
human beings at the Federal University of Viçosa, under 
the CAAE no 28144814.0.0000.5153, respecting the rules 
of Brazilian Legislation (resolution 12/466) on studies 
with humans.
After the treadmill test (TT) and before the start of the 
intervention program with exercise, all volunteers were 
undergoing anthropometric assessments and blood tests 
for metabolic control analysis.
The participants were randomly divided into two 
groups, with distinct exercise programs. One group 
performed aerobic training (AT) and the other strength 
training (ST). The study was divided into two phases, 
both with 10 weeks.
At the end of the first phase, the participants were sub-
jected to the same evaluations as at the beginning of the 
program. After the first reevaluations (10  weeks), the 
participants started the second phase, with changes in 
programs and the intensity of the exercises. At the end 
of the second phase (20  weeks), the participants were 
subjected to the same initial assessments again. At the 
beginning of the study, all participants were told not to 
change their eating habits, unless prescribed a calorie 
reduced food plan. In addition, physicians were asked not 
to change any medication being given to the patients dur-
ing the 20 weeks of training.
Sample
Sampling of the present study was selected from the 
Viçosa  Hiperdia Reference Center, which covers 9 cit-
ies in the Zona da Mata region of Minas Gerais. Among 
the 547 diabetic patients, assisted until April 2014, 95 
patients were pre-selected through a registration form 
belonging to the Secretariat, which contained name, 
phone number, date of birth, type of disease and location 
of residence. After analyzing their charts and consider-
ing exclusion criteria, 43 patients were pre-selected to 
participate in the program. The subjects were contacted 
by telephone and informed about the program and its 
goals. Twenty-three individuals showed interest and were 
selected to participate in the intervention program with 
aerobic or strength exercises during a 20 week period.
As criteria for inclusion, patients with DM 2, hyperten-
sive or not, of both genders, older than 18, without rou-
tine or organized workouts were considered. As exclusion 
criteria, were considered patients with symptomatic 
ischemic heart disease or with electrocardiographic signs 
of ischemia at rest or at TT, pressure instability during 
TT, kidney diseases, peripheral distal symmetric poly-
neuropathy, autonomic neuropathy, severe retinopathy, 
patients with severe osteoarticular diseases, with chronic 
diseases, drug addicts and people with psychological dis-
orders which prevented the insertion in the proposed 
study.
As such, by the end of the first phase, the study sample 
was made up of only 14 volunteers: 4 type 2 diabetics and 
10 hypertensive type 2 diabetics (5 men and 9 women). 
The second phase ended with 11 patients, 4 type 2 dia-
betics and 7 hypertensive type 2 diabetics (5 men and 6 
women).
The minimum size of the sample was defined using the 
variation coefficient previously obtained for hemoglobin 
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A1c (HbA1c) (16  %) in the literature [15–17] taking into 
consideration a 15 % variation around the average, with a 
minimum number of five individuals in each group to ver-
ify statistical differences with a 5 % level of significance [18].
All participants selected for the study were met by the 
Hiperdia Center of Viçosa-MG, and were informed about 
the methodology, the objectives of the study and signed 
an informed consent form. Additional file 1: Figure S1 is 
showing the study flow chart.
Assessments
All patients were submitted to clinical and cardiological 
testing with TT in a ramp protocol prior to participation 
in the study, conducted by a cardiologist in the Center 
itself. In addition, biochemical tests were conducted 
before the start of the exercise program, after 10  weeks 
and at the end of the 20 weeks of training, in accredited 
laboratories by the Unified Health System (SUS). The tests 
comprised a glycemic profile (fasting glucose, postpran-
dial glucose, hemoglobin A1c and their blood glucose 
average), insulin serum, lipid profile (total cholesterol, 
HDL, LDL and VLDL), and triglycerides. Normality crite-
ria of the assessed blood parameters followed the proposal 
given by the Brazilian Society of Diabetes [6]. For insulin 
resistance, the HOMA-IR index proposed by Matthews 
[19] was calculated. The patients also underwent anthro-
pometric evaluations at the beginning of the program, 
after 10 weeks and at the end of 20 weeks of training.
Body weight was measured using a Mercy® scale 
(model LC 200, Brazil, 2010), with the scale ranging from 
1 to 200 kilograms and with a 50-g precision. The stature 
was obtained using a Welmy® stadiometer (model R110, 
Brazil, 2009) with a scale ranging from 0.8 to 2.00 m with 
1 mm accuracy. The body mass index (BMI) was calcu-
lated using the formula BMI =  body weight (kg)/height 
(m)2. The adopted cutoffs were those recommended by 
the World Health Organization [20].
The waist, abdomen and hips circumferences were 
measured using a retractable measuring tape and flexible 
Proximus® (Rio de Janeiro, Brazil, 2013), with a range of 
0–200  cm and 1  mm accuracy. Waist/hip ratio (WHR) 
were obtained by dividing the perimeter of the waist by 
the hip and following the classification criteria proposed 
by the World Health Organization [21].
For all evaluations the methodological recommen-
dations proposed by the International Standards for 
Anthropometric Assessment (ISAK) [22] were followed, 
being carried out by two physical education teachers 
trained using the cited technical manual.
Exercise programs
The participants were randomly divided into two groups, 
with distinct exercise programs. One group performed 
AT and the other ST. In both cases the program lasted 
20 weeks and was divided into two 10 week phases, with 
a frequency of 3 weekly sessions.
Initially, with the purpose of properly adapting the 
physiological and motor capabilities of the patients, the 
duration of the main part of the session was initially 
20 min, evolving to 30 min in week two and to 40 min in 
the subsequent week, for both intervention groups.
For both groups, the warm up was performed on 
equipment like a treadmill, stationary bike, elliptical, or 
arm ergometer, for 10 min at a max intensity of 50 % of 
the maximum heart rate (MHR) estimated by the equa-
tion MHR = 208 − (0.7 × age) [23]. At the end the cool 
down was composed of active and passive stretching 
exercises. The average time of each full session of exercise 
was between 50 and 60 min beginning from week three.
Exercise procedures were based off of the general 
guidelines of exercise prescribed for diabetics proposed 
by the American Diabetes Association [8], the Brazilian 
Society of Diabetes [6] and for hypertensive individuals 
proposed by the American College of Sports Medicine 
[24].
Keeping in mind the safety of the volunteers, capillary 
blood glucose measurements and BP were taken before, 
during and after exercise, with daily records of the three 
measurements for each participant, in addition to the 
effort perception index (EPI) using the Borg [25] scale 
during the exercise, for both groups. For blood glucose, 
measurements were taken using the AccuChek Roche 
glucometer® Performa (Mannheim, Germany, 2009) 
while for BP the stethoscope and aneroid sphygmoma-
nometer Premium® (Wenzhou Instrument Co., China, 
2014) were used.
All training sessions were individually supervised by 
physical education professionals. A presence adherence 
≥80 % during the training sessions was considered a cri-
terion so that the patient could be included in the final 
sample.
The main part of the exercise sessions of the two 
groups had different methodologies. One had the unique 
execution strength exercises, while the second had aero-
bic exercises. The ST group followed a sequence of ten 
exercises: rowing, squat, bench press, rowing with dumb-
bells, knee extensions with ankle weights, dumbbell 
shoulder press, dumbbell curls, dumbbell leg extensions, 
standing calf raises, triceps pull down and abdominal 
crunches in the first phase of the program. A circuit 
method was used, but at intervals of 10–15  s between 
exercises. Seeking an adequate adaptation of neural, joint 
and muscle systems, the first 2 weeks the volunteers per-
formed 2 sets of 15 repetitions for each exercise and from 
the third week began to perform 3 sets. The execution of 
the repetitions of the strength exercises was performed 
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in a continuous, controlled manner with moderate speed 
and similar durations between concentric and eccentric 
phases.
Due to the low physical fitness and motor skills of 
patients, the initial loads of each exercise were set accord-
ing to the perception of effort, using the scale of 6–20 
proposed by Borg [25], and as improvements occurred 
in the movement pattern and physical conditioning, the 
weights were adjusted. The scale values used were from 
11 to 13, representing moderate effort [26]. We opted for 
the limitation and control of the training load on strength 
exercises based on the subjective perception of effort due 
to the low levels of physical fitness, motor skills and the 
fact of dealing with high risk patients. Load testing or 
maximum repetitions would entail an effort inconsistent 
with participants’ health conditions, which would raise 
the risk of adverse events. Therefore, the training loads 
were adjusted according to the improvement in the phys-
ical fitness and motor skills of the participants, and even 
with load adjustments the perception of the effort of the 
participants always remained between 11 and 13.
During the second phase of the program there was 
a change in the exercise program. Participants kept the 
sequence of 10 exercises in a circuit with a frequency of 3 
weekly sessions and keeping the muscle groups exercised 
during the previous routine. Repetitions were changed 
to 12 per exercise and participants followed the follow-
ing sequence: front lat pull down, unilateral squats, bar-
bell bench press, unilateral leg raise (standing), lateral/
front raises, standing calf raises, standing biceps cable 
curl, cable triceps pushdown, and unilateral cross crunch. 
During the first week of the second phase of the program, 
the participants performed 2 series, moving to 3 series on 
the second week until the end of the program.
For the AT group, with an aim of proper physiological 
and motor adaptation, the initial duration of the main 
part of the session was 20 min in the first week, 30 min in 
the second week, and 40 min the subsequent weeks. The 
training was performed on the treadmill, exercise bikes, 
elliptical and an upper body cycle ergometer. Initially 
there was a proposal to control training intensity through 
the MHR percentage, setting it at 60 % for the main part 
of the training. However, due to some patient’s use of 
adrenergic beta-blockers to control BP, the decision was 
made to use the subjective effort perception scale, pro-
posed by Borg [25], which was used for the control of 
training loads of these patients. For diabetic patients who 
did not show symptoms of SH or use beta blockers, the 
initial plan was utilized.
The lower and upper limit range from 6 to 20, respec-
tively, was adopted for the control of the training ses-
sion intensity. Another justification for the use of this 
methodology of intensity control was low physical 
fitness, motor skills and participant mobility. The scale 
values used were from 11 to 13, representing moder-
ate effort [26], and were in accordance with the indica-
tions for prescribing exercises proposed by the Brazilian 
Society of Diabetes [6] and American Diabetes Associa-
tion [8].
In the second phase of the program a change was made 
to the intensity of training, from 60 to 70 % of the MHR 
formula stipulated by Tanaka et al. [23]. For patients who 
use beta-blockers, the scale of perceived exertion [25] 
was used. During the first week of the second phase of 
the program the patients performed 30 min in the main 
part of the session, achieving 40 min during the second 
week until the end of the program. Although it is still 
considered a moderate intensity on the Borg scale [25], 
the change from 60 to 70 % MHR can be considered a real 
change of intensity because the participants exercised at 
a higher percentage of MHR, but kept EPI between 11 
and 13. Even patients on beta blockers reached this level 
of MHR.
Statistical analysis
For the presentation of data, descriptive statistics was 
used. For the analysis of the distribution of data the Sha-
piro–Wilk test was used. For the analysis of the responses 
of all analyzed variables during the three periods (base-
line, 10 weeks and 20 weeks), as well as verifying changes 
over time and the differences between the groups, a 
mixed ANOVA model was used. The effect size was cal-
culated for the magnitude of observed effect [27]. A sig-
nificance level of p < 0.05 was considered.
The standard deviation (SD) and intraclass correlation 
coefficient (r) of the initial assessment (baseline) and of 
the 20 weeks were used to estimate the standard error of 
measurement (SEM). The formula SEM = SD × √1 − r 
was used. The Minimum Detectable Change (MDC) was 
used to define the smallest change that probably reflects 
a real change rather than a measurement error. The 
MDC is more often based on a 90 % confidence interval 
(z = 1.65) [28].
The MDC90 was calculated using the formula MDC90 
= 1.65 × SD × √(2 ×  [1 − r]), where 1.65 is the value 
of z of two tails for a 90 % confidence interval, SD is the 
standard deviation, √2 represents the variation of the 
two measurements, and r is the intraclass correlation 
coefficient. All analyses were performed using the soft-
ware SPSS (SPSS Inc®, version 20).
Results
Tables 1 (ST) and 2 (AT) present the results of the com-
parison means of anthropometric data of the two groups 
at three periods during the intervention: baseline, 10 and 
20 weeks.
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The anthropometrical variable behavior analysis did 
not show statistically significant changes between the 
periods for either groups. In addition, the analysis under-
taken showed no interaction between the times and type 
of exercise or differences between the types of training on 
the behavior of the variables.
For hip circumference, the analyses showed no sig-
nificant changes between periods in either groups 
(p = 0.464), but the hip circumference averages differed 
in the three periods evaluated (p  =  0.02) between the 
groups. The hip circumference averages observed were 
significantly higher in the AT group when compared with 
the ST group at baseline (p = 0.04), 10 weeks (p = 0.02) 
and 20 weeks (p = 0.05).
The blood variable comparisons results are shown in 
Tables 3 (ST) and 4 (AT). For hemoglobin A1c (HbA1c) 
significant changes were observed over the studied 
periods (p  =  0.001), represented by a greater effect 
size r  =  0.76, but there were no significant differences 
in the average HbA1c values between the two groups 
(p  =  0.743). No significant interactions were found 
between the periods and type of exercise (p = 0.489), that 
is, changes in the average HbA1c were equivalent in the 
two types of exercises. The reductions in the averages 
of HbA1c occurred between the baseline and 10  weeks 
(p  =  0.03), and between the baseline and 20  weeks 
(p  =  0.01), with ST group starting with the highest 
Table 1 Comparisons of  the anthropometric variables 
at baseline, 10 and 20 weeks for the ST group (n = 5)
Results presented in mean and standard deviation values
Significance level p < 0.05
BMI body mass index, WHR waist hip ratio, Circ. circumference
Baseline 10 weeks 20 weeks
Age (years) 57 ± 12 – –
Body weight (kg) 71 ± 5 71 ± 6 71 ± 5
Height (m) 1.62 ± 0.09 – –
BMI (kg/m2) 27 ± 3 27 ± 4 27 ± 4
Waist Circ. (cm) 93 ± 4 97 ± 9 95 ± 7
Abdomen Circ. (cm) 98 ± 5 99 ± 7 99 ± 6
Hip Circ. (cm) 97 ± 2 98 ± 7 98 ± 5
WHR 0.95 ± 0.05 0.98 ± 0.06 0.97 ± 0.08
Table 2 Comparisons of  the anthropometric variables 
at baseline, 10 and 20 weeks for the AT group (n = 6)
Results presented in mean and standard deviation values
Significance level p < 0.05
BMI body mass index, WHR waist–hip ratio, Circ. circumference
Baseline 10 weeks 20 weeks
Age (years) 54 ± 9 – –
Body weight (kg) 94 ± 31 93 ± 30 91 ± 29
Height (m) 1.60 ± 0.1 – –
BMI (kg/m2) 36 ± 10 35 ± 9 35 ± 9
Waist Circ. (cm) 110 ± 24 108 ± 23 107 ± 20
Abdomen Circ. (cm) 116 ± 25 114 ± 22 113 ± 21
Hip Circ. (cm) 111 ± 13 113 ± 10 108 ± 9
WHR 0.98 ± 0.11 0.95 ± 0.14 99 ± 0.16
Table 3 Comparisons of the biochemical variables at baseline, 10 and 20 weeks for the ST group (n = 5)
Results presented in mean and standard deviation values
Significance level p < 0.05
HbA1c hemoglobin A1c
a,c p = 0.03 (baseline and 10 weeks)
b,d p = 0.01 (baseline and 20 weeks)
Baseline 10 weeks 20 weeks
Fasting glycemic levels (mg/dL) 174 ± 92 129 ± 46 157 ± 86
Postprandial glycemic levels (mg/dL) 187 ± 76 142 ± 96 187 ± 100
HbA1c (%) 9.2 ± 1.9a,b 7.9 ± 1.2a 7.4 ± 0.9b
Average glycemic level (mg/dL) 217 ± 56c,d 179 ± 36c 165 ± 29d
Total cholesterol (mg/dL) 174 ± 49 155 ± 23 169 ± 40
LDL (mg/dL) 106 ± 51 83 ± 8 93 ± 25
VLDL (mg/dL) 25 ± 20 27 ± 14 28 ± 17
HDL (mg/dL) 45 ± 3 45 ± 3 48 ± 8
Triglycerides (mg/dL) 128 ± 97 136 ± 72 127 ± 55
Seric Insulin (μUi/mL) 30 ± 24 23 ± 21 18 ± 14
HOMA‑IR 13 ± 14 6 ± 4 5 ± 4
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average value and finalizing the exercise program with 
average value lower than the AT group.
The average blood glucose values changed significantly 
over the studied periods (p = 0.001), with r = 0.76 rep-
resenting a greater magnitude of effect. However, there 
were no significant differences in mean values of this 
parameter between the two groups (p = 0.742). Also, no 
significant interactions were observed between the peri-
ods and the type of exercise (p = 0.487), even though the 
changes occurred similarly in both groups. The reduc-
tions in blood glucose average values occurred between 
the baseline and 10  weeks (p  =  0.03) and between the 
baseline and 20  weeks (p  =  0.01), with the ST group 
starting with the highest average value and finalizing the 
exercise program with an average value lower than the 
AT group. All other variables evaluated showed no sta-
tistically significant changes during the exercise program.
The results of the MDC90 for HbA1c is presented in 
Table  5. For the average HbA1c, which showed statisti-
cally significant difference in the averages of the two 
groups, 40  % of the subjects belonging to the ST group 
and 33  % belonging to the AT group reached minimal 
changes in their averages.
Additional file 2: Figure S2 presents the average HbA1c 
individual behavior throughout the 20 week intervention 
for the ST and AT groups. It was found that individuals 
who obtained greater reductions in the average HbA1c 
were the ones who presented greater averages at the 
beginning of the program.
Discussion
The objective of the present study was to evaluate and 
compare the effects of aerobic exercise and strength 
training programs on glycemic control in patients with 
DM 2 treated through the public health system. Regular 
physical exercise is an important component in the con-
trol and treatment of DM 2 [9], promoting benefits on 
insulin sensitivity, plasma glucose homeostasis, increase 
in daily energy expenditure [10], cardiovascular risk 
reduction, and contribution to weight loss and general 
well-being [8].
Even without statistically significant changes in any 
anthropometric variables (Tables  1, 4), Tables  2 and 5 
present statistically significant differences in average 
HbA1c and the estimated average glucose in both the ST 
and AT groups for patients who completed 20 weeks of 
training. Although the reductions were statistically non-
significant, the average fasting glucose and postprandial 
glucose levels presented relevant reductions, except for 
the postprandial glucose of the ST group.
Even considering that the fasting glycemic levels value 
is insufficient for monitoring glycemic control in subjects 
with DM, this measure has important clinical relevance, 
because it reflects a specific time point of these patients’ 
glycemic levels [6]. In recent years the postprandial hyper-
glycemia has been recognized as an independent risk fac-
tor for the development of cardiovascular complications 
and oxidative stress in patients with DM [6], and struc-
tured exercise programs have shown to play an important 
role in glycemic control during the day, causing increased 
sensitivity to insulin for up to 48  h after the workout, 
which can assist in preventing hyperglycemic spikes [29].
In absolute numbers, the average reductions in HbA1c 
were 1.3 and 1.8  % for the ST group and 1.4 and 1.1  % 
for the AT group in comparison to baseline values with 
10 and 20  weeks, respectively. The estimated average 
glucose values reduced significantly in comparison to 
Table 4 Comparisons of the biochemical variables at base-
line, 10 and 20 weeks for the AT group (n = 6)
Results presented in mean and standard deviation values
Significance level p < 0.05
HbA1c hemoglobin A1c
a,c p = 0.03 (baseline and 10 weeks)
b,d p = 0.01 (baseline and 20 weeks)
Baseline 10 weeks 20 weeks
Fasting glycemic levels 
(mg/dL)
187 ± 107 153 ± 56 146 ± 66
Postprandial glycemic 
levels (mg/dL)
225 ± 172 161 ± 43 158 ± 82
HbA1c (%) 8.6 ± 2.5a,b 7.2 ± 1.7a 7.5 ± 1.7b
Average glycemic levels 
(mg/dL)
202 ± 74c,d 161 ± 51c 171 ± 49d
Total cholesterol (mg/dL) 193 ± 26 187 ± 23 167 ± 12
LDL (mg/dL) 103 ± 29 99 ± 23 74 ± 27
VLDL (mg/dL) 41 ± 22 41 ± 12 49 ± 13
HDL (mg/dL) 53 ± 11 49 ± 14 49 ± 15
Triglycerides (mg/dL) 183 ± 113 219 ± 112 177 ± 80
Seric Insulin (μUi/mL) 14 ± 9 13 ± 6 11 ± 9
HOMA‑IR 5 ± 4 5 ± 2 4 ± 3
Table 5 Subjects who reached the minimum detectable 
change criterion in  glycemic control at  90  % confidence 
(MDC90)
SD standard deviation, MDC90 minimum detectable change at 90 % confidence, 




 Strength 2.52 40
 Aerobic 1.73 33
Average glycemic level (mg/dL)
 Strength 72.23 40
 Aerobic 49.77 33
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the baseline with 10 and 20  weeks. For the ST group, 
the reductions were 18 and 24 %, while for the AT group 
these reductions were 20 and 15 %.
Studies have shown that structured aerobic exercise or 
resistance exercises reduce HbA1c levels, on average, about 
0.6 % in patients with DM 2 [8]. The reduction in HbA1C 
levels is associated with a decreased risk of cardiovascular 
events and microvascular complications, so regular physi-
cal exercise over time can assist in effective glycemic con-
trol, reducing the risk of vascular complications [13]. In 
absolute numbers, a 1 % reduction in HbA1c value is asso-
ciated with a reduction between 15 and 20 % of the risk of 
cardiovascular problems and 37 % of the risk of microvas-
cular complications [15]. Values higher than the percentage 
above quoted were found by the present study.
Interventions using structured exercise programs 
with a minimum of 8  weeks showed positive results 
in glycemic control in DM patients, commonly with-
out significant changes in BMI [8, 11, 12], which cor-
roborates the results of the present study. Even with 
statistically or clinically significant reductions in gly-
cemic control parameters, anthropometric parameters 
such as body weight, BMI, WHR and circumferences 
showed no relevant changes over the 20 weeks of train-
ing, as shown in Tables  1 and 4. This result can be 
explained by not having caloric restrictions planned 
and, perhaps, the volume and intensity of the exercises 
prescribed. According to Sigal et  al. [12], most of the 
studies which succeeded in the loss and control of body 
weight involved the combination of exercise with diet 
and behavioral changes, and interventions with only 
exercise tended to produce modest changes in body 
weight, and the volume of exercise for weight loss was 
greater than what is needed to promote glycemic con-
trol and cardiovascular health.
The blood analysis parameters related to long-term 
glucose control (HbA1c and estimated average glycemic 
levels) demonstrates a similarity in the responses sub-
mitted by individuals of the two intervention groups. As 
occurred in the comparisons of the general averages over 
the 20  weeks of intervention, the analysis by MDC90 to 
HbA1c, even though there were different values between 
the groups, did not show differences between them when 
the number of subjects who attained a real reduction in 
these values were considered.
Individually, those who reached values above the 
MDC90 were those who presented a higher value on the 
basis of the variable analyzed which is justified, according 
to Haley and Fragala-Pinkhan [30], subjects that begin 
with higher values (worst metabolic control) in a given 
evaluation tend to have greater ability to achieve real 
changes than those that present smaller values (better 
metabolic control).
The use of the MDC90 allows the insertion of a new 
type of behavior analysis for the glycemic metabolism 
with the intervention through physical exercise, so that 
answers can be considered important from the point of 
view of clinical control, individually, regardless of the 
level of significance of the comparisons.
The present study presented the results of exercise pro-
grams as adjuvant therapy to control the DM 2 in sec-
ondary healthcare. Although clinically relevant results 
were found in the improvement of the metabolic control 
of participants of both groups, the study presented limi-
tations with the reduced sample size due to losses from 
adherence and exclusion criteria. It is important to con-
sider that the Hiperdia is a center of secondary health 
attention, linked to the Brazilian Public Health System. 
The Hiperdia participants are people from low socio-
economic status, low human development index, low 
educational background and very low familiar income. 
These participants have intellectual difficulties in under-
standing, and as consequence to adherence, some thera-
pies, as physical activity and nutritional orientations, as 
an important part of DM treatment. Some of the patients 
cannot participate in the exercise interventions because 
of conflicting working hours, while others, living far from 
the center have not enough money for the public trans-
port 3 days a week for 20 weeks to get to the training ses-
sions, which contributes directly to the small sample size.
Another limiting factor would be the most pronounced 
differences in body weight and BMI between the two 
groups at baseline. However, the randomization pro-
cess was done, but the reduction of participant number 
by loss of adherence or clinical complications by many 
patients, inevitably, increasing these differences. Initially 
both groups composed by 23 selected patients for the 
intervention sessions showed smaller differences in body 
mass and BMI than the groups completing 20  weeks of 
intervention sessions. However, despite these showed 
average differences between groups at the end of the 
study intervention, it was not enough to produce statisti-
cally significant differences.
It is important to stress that the option to use esti-
mated maximal heart rate percentage to training control 
it is a procedure recommended by guidelines as Brazil-
ian Diabetes Society [6] and American College Sports 
Medicine joint with American Diabetes Association 
[31]. It is a tool habitually used to control interventions 
in the therapeutic practice with patients with a range 
of health problems, among them diabetes and hyper-
tension. We are aware that the best method to evaluate 
oxygen uptake, anaerobic threshold and maximal heart 
rate is through progressive maximal exercise testing 
with a gas analyzer. However, analyzing the Hiperdia 
participants characteristics (low physical fitness, limited 
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motor behavior, low ergometer habituation, medicine 
use, and all included risk factor), and discussing with 
center cardiologists, we did the option to not adopt this 
type of test. A progressive maximal exercise testing with 
patients with all cited conditions probably will produce 
false positive results and will not introduce additional 
information to the performed test, considering the 
study objective, but could introduce complications and 
increase patients stress and burden. Moreover, the test 
applied before patients starting the exercise program 
was exclusively to evaluate physical activity readiness, in 
the clinical perspective.
It is important to consider these results as a start point 
of a free and new supervised exercise program method-
ology in the Brazilian Public Health System, specifically 
in the secondary health attention with high risk patients. 
We strongly believe that the implantation of this program 
in other centers will create new opportunities for a large 
number of patients increasing the recruitment and par-
ticipation adherence.
Conclusion
The data submitted demonstrated that using both aerobic 
exercise and ST can aid in the metabolic control of patients 
with DM 2, even without changes in anthropometry or 
caloric intake control. The characteristics of patients seen 
by the Hiperdia Center of Viçosa and that composed the 
study sample, age and the high prevalence of physical inac-
tivity may have acted as an ineffective metabolic control 
and may have contributed to more pronounced reductions 
than the results of some previous studies.
Both the aerobic exercises and weight training, pre-
scribed from the proposed methodology, can effectively 
help the metabolic control of patients seen in secondary 
healthcare and that these individuals should be encour-
aged to enter into supervised exercise programs involv-
ing both types of exercises, with a suggestion to increase 
the frequency to 5 days a week, in addition to a stricter 
dietary control. To our acknowledgement this is the first 
study to use MDC as outcome measure for exercise inter-
vention as adjunct therapy to glycemic control for dia-
betic patients, our results can be useful as reference for 
future studies or intervention, but with caution given the 
small sample size. New studies are warranted to verify 
the reproducibility of our findings.
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